Clinical Trials on Drug-Eluting Stents

Total 5825 results

North Texas Veterans Healthcare System

Terminated

Serial Evaluation of Drug-Eluting Stents Using OCT (STRUT-OCT) (STRUT-OCT)

Optical Coherence Tomography (OCT) | Percutaneous Coronary Intervention (PCI) | Drug Eluting Stents (DES) | Uncovered and Malapposed Stent Struts

United States
Yonsei University

Unknown

Aspirin Mono Therapy 12-months After Drug-eluting Stents Implantation (statin)

Drug-eluting Stent (DES)

Korea, Republic of
Shanghai MicroPort Medical (Group) Co., Ltd.

Unknown

Comparison Three vs Twelve Months of Dual Anti-Platelet Therapy After Stent Implantation

Percutaneous Coronary Intervention | Drug-Eluting Stents

China
Shanghai MicroPort Medical (Group) Co., Ltd.

Active, not recruiting

Firehawk™ Coronary Stent System in the Treatment of Coronary Chronic Total Occlusion Lesion(s)

Percutaneous Coronary Intervention | Drug-Eluting Stents | Tomography, Optical Coherence

China
Liuhuaqiao Hospital

Unknown

Angiographic and Intravascular Ultrasound (IVUS) Follow-up After Simultaneously Implanted Different Drug-eluting Stents in Same Individuals (AIFSIDDES)

Drug Eluting Stent

China
China National Center for Cardiovascular Diseases

Recruiting

STrategies of Scheduled Drug-coated Balloons (DCB) Versus Conventional DES for the interveNTional Therapy of de Novo Lesions in Large Coronary vESSels (STENTLESS) Trial (STENTLESS)

De Novo Stenosis | Drug-coated Balloon | Drug-eluting Stent

China
Institute of Cardiology, Warsaw, Poland

Unknown

Comparison of Safety and Efficacy of Two Different Drug Eluting Stents Implanted Into Saphenous Vein Grafts

Stenosis in Saphenous Vein Graft, Drug Eluting Stent

Poland
Seoul National University Hospital

Terminated

Proper Fractional Flow Reserve Criteria for Intermediate Lesions in the Era of Drug-eluting Stent (DEFER-DES)

Coronary Angiography | Fractional Flow Reserve, Myocardial | Drug-eluting Stents

Korea, Republic of
Seoul National University Hospital

Unknown

Kor PCI - CAD Patients Treated With PCI: Analysis of the Korean Nationwide Health Insurance Database

Coronary Artery Disease | Drug-coated Balloon | Drug-eluting Stents
Shanghai Zhongshan Hospital

Not yet recruiting

A Comparison Between FFR Guided and CAG Guided Treatment Using DEB in ISR of DES

Coronary Artery Disease | In Stent Restenosis | Drug Eluting Stent
Azienda Ospedaliera Città della Salute e della...

Completed

Outcome of CHAllenging lesioNs and Patients Treated With Polymer Free Drug-CoatEd Stent (CHANCE)

Coronary Disease | STEMI | Drug Eluting Stent
Yonsei University
Terumo Corporation

Active, not recruiting

Safety and Efficacy of the Ultimaster Stent

Coronary Artery Disease | Drug-eluting Stents

Korea, Republic of
Wonkwang University Hospital

Completed

Mono Antiplatelet and Colchicine Therapy (MACT)

Acute Coronary Syndrome | Drug-Eluting Stents

Korea, Republic of
Kliniken Ludwigsburg-Bietigheim gGmbH
Klinikum Ludwigshafen; Universitätsmedizin Mannheim

Unknown

Comparison of a Plastic Stent Without Central Lumen With Self Expandable Metal Stents in Patients With Malignant Distal Biliary Obstruction (VIADUCT)

To Evaluate Patency of the Viaduct Stent in Comparison to Metal Stents

Germany
University Hospital Inselspital, Berne

Completed

Independent OCT Registry on Very Late Bioresorbable Scaffold Thrombosis (INVEST)

Drug-Eluting Stents | Coronary Thrombosis | Tomography, Optical Coherence

Austria, Belgium, France, Germany, Hong Kong, Italy, Netherlands, Singapore, Spain, Switzerland
Thorax Centrum Twente

Completed

Change of Dual Antiplatelet Therapy in Patients With Acute Coronary Syndrome (CHANGE DAPT)

Acute Coronary Syndrome | Percutaneous Coronary Intervention | Drug-Eluting Stents

Netherlands
The Young Investigator Group of Cardiovascular...

Withdrawn

Very Long Versus Overlapping Stents in Long Coronary Lesions

Coronary Artery Disease | Chronic Coronary Syndrome | Drug Eluting Stents

Egypt
Central Clinical Hospital of the Ministry of Internal...

Completed

First-in-man Sirolimus-eluting Prolim® Stent Registry

Sirolimus-eluting Stainless Steel Coronary Stent Prolim®
Yonsei University
Dio

Recruiting

CREATE Trial, Prospective, Observational Study

Coronary Artery Disease | Drug Eluting Stent

Korea, Republic of
Yonsei University
Severance Hospital; Genoss Co., Ltd.

Recruiting

Genoss DES in Patients With a High Risk of Ischemic Events (GENTLE Registry)

Coronary Artery Disease | Drug-eluting Stent

Korea, Republic of
Associations for Establishment of Evidence in Interventions
Medtronic Vascular

Completed

A Prospective Multicenter Post Approval Study to Evaluate the Long-term Safety and Efficacy of the Resolute Integrity in the Japanese All-comers Patients With Coronary Artery Disease (PROPEL)

Coronary Artery Disease | Drug-eluting Stent

Japan
Genoss Co., Ltd.

Recruiting

Efficacy of OSFIT Drug-Eluting Stent in Coronary Ostial Artery Stenosis

Coronary Artery Disease | Drug-eluting Stent

Korea, Republic of
Cardiva2 S.L.

Completed

Efficacy of Angiolite Stent vs a Second-generation Drug-eluting Stent Xience for Percutaneous Coronary Intervention

Coronary Artery Disease | Drug-eluting Stent

Spain
The Catholic University of Korea
Seoul St. Mary's Hospital; Saint Vincent's Hospital, Korea; Bucheon St. Mary's... and other collaborators

Completed

CathOlic Medical Center percutAneous Coronary inTervention Registry (COACT) (COACT)

Coronary Artery Disease | Biomarker | Cholesterol | Polymorphism | Drug Eluting Stent

Korea, Republic of
Beijing Anzhen Hospital

Recruiting

Genotyping GUided Antiplatelet theRapy in pAtieNts Treated With Drug Eluting stEnts (GUARANTEE)

Angina, Stable | Acute Coronary Syndrome | Drug-Eluting Stents | Genotype

China
Shandong Branden Med.Device Co.,Ltd
Shandong Rientech Medical Tech Co., Ltd.

Not yet recruiting

Study on Absorbable Zinc Alloy Drug Eluting Coronary Stent System

Coronary Heart Disease | Drug Eluting Stent
Beijing Anzhen Hospital

Enrolling by invitation

Safety and Efficacy of Drug-Coated Balloon Angioplasty for the Treatment of Chronic Total Occlusions

Coronary Artery Disease | Percutaneous Coronary Intervention | Coronary Occlusion | Chronic Total Occlusion of Coronary Artery | Drug-Eluting Stents

China
Shanghai MicroPort Medical (Group) Co., Ltd.

Recruiting

Comparison One vs Six Months of Dual Antiplatelet Therapy After Implanted Firehawk TM Stent in High Bleeding Risk Patients With Coronary Artery Disease

Coronary Disease | Percutaneous Coronary Intervention | Dual Antiplatelet Therapy | Drug Eluting Stent

China
Xijing Hospital

Unknown

In-stent Repair and Vessel Reaction of STEMI Patients With OCT

Percutaneous Coronary Intervention | ST-Elevation Myocardial Infarction | Optical Coherence Tomography | Drug-eluting Stents

China
University Hospital of Patras

Not yet recruiting

REtrospective Analysis on the Use of COvered Stents for the Treatment of the Dysfunctional Vascular Access (RECOVA)

Study Focuses on the Use of Covered Stents (Stent Grafts) for the Treatment of Dysfunctional Vascular Access of Hemodialysis Patients
China National Center for Cardiovascular Diseases

Not yet recruiting

24 Versus 12-Month Dual Antiplatelet Therapy After Drug-Eluting Stent in Patients With Elevated Lipoprotein(a) Levels (DAPT-Lp(a))

Coronary Artery Disease | Dual Antiplatelet Therapy | Elevated Lipoprotein(a) Level | Drug-Eluting Stent

China
Seoul National University Hospital

Completed

The Impact of Early Surgery and Maintenance of Antiplatelet Therapy on Intraoperative Bleeding and Major Adverse Cardiovascular Event After Percutaneous Coronary Intervention

Acute Coronary Syndrome | Aspirin | Drug-eluting Stent

Korea, Republic of
Zhong Wang
Shanxi Zhendong pharmaceutical Co. LTD.

Completed

Post-marketing Safety Surveillance of Compound Kuh-seng Injection: a Registry Study

Adverse Drug Events | Adverse Drug Reactions | Severe Adverse Events | Safety Surveillance | Severe Adverse Reactions

China
Yinyi(Liaoning) Biotech Co., Ltd.

Completed

Bingo Drug-eluting Balloon in Bifurcation

Bifurcation Lesions | Drug Eluting Balloon

China
University Medical Centre Ljubljana

Completed

Definite Stent Thrombosis in Comatose Out of Hospital Cardiac Arrest Survivors (ST OHCA)

Stent Thrombosis | Drug Eluting Stent | Out of Hospital Cardiac Arrest | Therapeutic Hypothermia

Slovenia
Zhong Wang
Shanxi Zhendong Pharmacy Co., Ltd

Recruiting

Post-marketing Safety Surveillance of Qizhi Tongluo Capsules:a Registry Study.

Adverse Drug Events | Adverse Drug Reactions | Severe Adverse Events | Safety Surveillance | Severe Adverse Reactions

China
Lin Zhao

Recruiting

Effect of Evolocumab on Chronic Total Occlusions (EVOLO-CTO)

In-stent Restenosis | Major Adverse Cardiovascular Events

China
Sinomed Neurovita Technology Inc.

Recruiting

A Registry Study of Intracranial Atherosclerotic Stenosis Treatment by Intracranial Drug-eluting Stenting in China

Intracranial Arteriosclerosis | Drug-Eluting Stents | Intracranial Artery Stenosis | Stenosis Artery

China
National Taiwan University Hospital Hsin-Chu Branch

Unknown

DCB for Dialysis Access Stent Graft Restenosis

Hemodialysis Access Failure (Disorder) | Stent-Graft Restenosis | Arteriovenous Graft | Drug-coated Balloon

Taiwan
Ottawa Hospital Research Institute
McGill University; Canadian Institutes of Health Research (CIHR)

Completed

Information Systems-enabled Outreach Program for Adverse Drug Events (ISTOP-ADE)

Adverse Drug Events

Canada
Intermountain Health Care, Inc.

Completed

Response to Medication Registry

Adverse Drug Events

United States
Cedars-Sinai Medical Center
National Institutes of Health (NIH); National Institute on Aging (NIA)

Completed

Pharmacists and Pharmacy Technicians to Improve Admission Medication History Accuracy

Adverse Drug Events
China Academy of Chinese Medical Sciences

Completed

Hospital Intensive Monitoring of Adverse Drug Reactions of Qingkailing Injection In The Next Two Years

Adverse Drug Events | Adverse Drug Reactions

China
University of Massachusetts, Worcester
Agency for Healthcare Research and Quality (AHRQ); Baycrest Centre for Geriatric...

Withdrawn

Reducing Adverse Drug Events in the Nursing Home

Adverse Drug Events
Indiana University
Brigham and Women's Hospital

Completed

Improving Safety by Basic Computerizing Outpatient Prescribing

Adverse Drug Events

United States
Sultan Qaboos University

Completed

Impact of Medication Reconciliation Intervention on the Rate of Preventable Adverse Drug Events (ADEs) and Healthcare Utilization

Adverse Drug Events
VA Office of Research and Development

Completed

Implementation of Real-time ADE Surveillance and Decision Support (VA ADE)

Adverse Drug Events

United States
University of Massachusetts, Worcester
Agency for Healthcare Research and Quality (AHRQ); Qualidigm

Completed

Enhancing the Safety of Warfarin in Nursing Homes

Adverse Drug Events (ADEs)

United States
Eagle Pharmaceuticals, Inc.

Terminated

Efficacy and Safety Study of Ryanodex as Adjuvant Treatment in Subjects With Psychostimulant Drug-Induced Toxicity (PDIT)

Drug Toxicity Psychotropic Agents Psychostimulants

United States
University of Pittsburgh
RAND

Completed

Enhancing the Detection and Management of Adverse Drug Events in Nursing Homes

Adverse Drug Events

United States

Clinical Trials on Drug-Eluting Stents

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Bosnia & Herzegovina

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations